[Form 4] Sempra Insider Trading Activity

Rhea-AI Filing Summary

Marvell Technology, Inc. (MRVL) – Form 4 insider transaction

On 07/22/2025, director Rajiv Ramaswami was granted 3,082 Restricted Stock Units (RSUs), each convertible into one common share upon vesting. The award was reported at a cost basis of $0 and is held directly.

The RSUs vest 100 % on the date of the company’s next annual shareholder meeting. Following the grant, Ramaswami’s beneficial ownership in derivative securities is 3,082 units; no open-market purchases or sales of common stock were disclosed. As MRVL’s float exceeds 850 million shares, the award represents an immaterial <0.001 % stake and does not alter overall insider ownership trends.

Positive

• Alignment of interests: Director received equity that will vest with shareholder meeting, modestly enhancing alignment with investors.

Negative

• None.

Insights

Sell-side Semiconductor Analyst

TL;DR: Small RSU grant, routine compensation, no valuation impact.

This Form 4 reflects a standard equity award to a board member rather than a discretionary share purchase. At 3,082 shares, the grant is de-minimis relative to MRVL’s market cap and does not signal incremental bullishness or insider conviction. Vesting is tied to the next AGM, aligning the director’s incentives with near-term shareholder interests but leaving no immediate liquidity event. No other trades were reported, leaving the company’s insider transaction profile largely unchanged. Accordingly, the filing is not materially impactful for valuation or sentiment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Larroque Alexander Lisa

(Last) (First) (Middle)

488 8TH AVENUE

(Street)

SAN DIEGO CA 92101

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SEMPRA [ SRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Corp Affairs & HR

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/23/2025		S		1,576	D	$80	15,599.71	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	LISA LARROQUE ALEXANDER BY: Lisa H. Abbot, Managing Attorney - Corporate and Securities of Sempra and Attorney-In-Fact	07/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MRVL disclose in the 07/23/2025 Form 4?

Director Rajiv Ramaswami received 3,082 RSUs that convert to common stock at the next annual meeting.

Did the insider buy or sell Marvell shares on the open market?

No. The filing reports an equity grant; there were no open-market purchases or sales.

When will the RSUs granted to Rajiv Ramaswami vest?

The units vest 100 % on the date of Marvell’s next annual shareholder meeting.

How many Marvell shares does the director now beneficially own from this award?

He now holds 3,082 derivative units; the filing shows no additional common shares reported.

Is the transaction material to Marvell’s share count?

No. 3,082 shares represent <0.001 % of MRVL’s outstanding shares, making the impact negligible.